Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cyamemazine, contains the phenothiazine chromophore, is a neuroleptic agent used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki: 12 nM), 5-HT2A (Ki: 1.5 nM) and 5-HT2C (Ki: 75 nM) receptors antagonist with antipsychotic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 131.00 | |
50 mg | 6-8 weeks | $ 744.00 | |
100 mg | 6-8 weeks | $ 1,120.00 |
Description | Cyamemazine, contains the phenothiazine chromophore, is a neuroleptic agent used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki: 12 nM), 5-HT2A (Ki: 1.5 nM) and 5-HT2C (Ki: 75 nM) receptors antagonist with antipsychotic activity. |
Targets&IC50 | 5-HT2C receptor:12 nM (ki), 5-HT2A receptor:1.5 nM (ki), 5-HT3 receptor:75 nM (ki) |
In vitro | Cyamemazine shows a high affinity for dopamine receptors. It is consistent with its antipsychotic activity. At muscarinic receptors, the antagonist activity of Cyamemazine is consistent with its affinity for M1 (Ki: 13 nM), M2 (Ki: 42 nM), M3 (Ki: 321 nM), M4 (Ki: 12 nM), and M5 (Ki: 35 nM) receptors [1]. |
In vivo | Cyamemazine act as an antagonist at the 5-HT3, 5-HT2C, and 5-HT2A receptors in 5-HT3-dependent contraction of isolated guinea pig ileum and bradycardic responses in rats in 5-HT2C-dependent phospholipase C stimulation in the rat brain membrane, and in 5-HT2A-dependent contraction of isolated rat aorta rings and isolated guinea pig trachea. Acute administration of low doses of Cyamemazine can reduces extracellular dopamine and metabolite concentrations in rat striatum [1]. |
Molecular Weight | 323.46 |
Formula | C19H21N3S |
CAS No. | 3546-03-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cyamemazine 3546-03-0 GPCR/G Protein Neuroscience 5-HT Receptor inhibitor inhibit